Using a CD73 Activity Assay to Study the Adenosine Pathway and Cancer
Wednesday, 11 September 2019
Tumor Immunosuppression and a CD73 Activity Assay – To say cancer is complex would be an understatement. From the cause, to treatment, to living with the disease, nothing about it is easy. As one of the leading factors of death worldwide and the burden on families and the healthcare system as a whole, it’s no
- Published in Emerging Targets
No Comments